Latest filing published 16 Oct 2026 for Iambic Therapeutics, Inc..
Insider track record
No signal scores available.
Thomas F. Miller: trading record in brief
Filings by Thomas F. Miller span 2 companies, the busiest being Veracyte, Inc. and Iambic Therapeutics, Inc. We count 3 filings; the first trade dates from 3 September 2024 and the latest from 14 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 16 October 2026 came the latest disclosure, a share grant in Iambic Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas F. Miller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 132,200 shares0Common StockSEC:0002034921-26-000007:0
- 9,321 shares0Common StockSEC:0001384101-25-000093:0
- 16,507 shares0Common StockSEC:0001384101-24-000141:0
3 of 3 declarations
